ZUG, SWITZERLAND, Aug 23, 2013 (Menafn - Marketwired via COMTEX) --Today, PSI CRO, a full-service contract research organization,announced their expansion to India and the appointment of Dr. Radhika Bobba as Regional Director for India and the Asia-Pacific region.
PSI's decision to conduct clinical trials in India was made based on requests from our clients. The PSI Indian base is serving as the hub for continuous expansion into the entire Asia-Pacific region.
PSI has appointed Dr. Radhika Bobba as the Regional Director forIndia and the Far East. Dr. Bobba, based out of PSI Bangalore, is anMD with 18 years of industry experience in both Contract Research andPharma. "I am proud to lead the expansion of PSI into the Asia Pacregion," says Dr. Bobba. "This expansion is already showing tangibleresults in strengthening PSI's unique ability to deliver high qualityon-time clinical studies world-wide."
About PSI CRO AG: PSI is a privately-held, full-service contractresearch organization (CRO), operating globally. PSI positions itselfas a no-nonsense CRO capable of saving pharmaceutical sponsorsmillions of development dollars by consistently meeting clinicaltrial timelines. PSI's global reach supports the operations ofclinical trials across multiple countries and continents. PSI hasexceptionally high repeat and referral business rates that areindicative of a commitment to be the best CRO in the world asmeasured by clients and employees. Global headquarters are located inZug, Switzerland at 113a Baarerstrasse 6300. www.psi-cro.com